- Celcuity wins approval for breast cancer drug RevtorpykA small public biotech won approval for a breast cancer drug that was designed to improve on similar treatments from Novartis and Roche. The FDA on Tuesday cleared Celcuity's Revtorpyk in combina…Endpoints · 11d ago↗ source
- STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last yearPrescription drugs purchased under a controversial government discount program amounted to $100 billion in 2025, a 22.8% increase from the previous year.STAT · 11d ago↗ source
- What's next for BINSA, the House bill restricting China dealsAfter setting the industry ablaze last month, a bipartisan bill aimed at restricting US biotech companies from striking deals with Chinese counterparts is in limbo. The Biotech Investment Nationa…